Previous studies reported that coronavirus disease 2019 (COVID‐19) was likely to result in
liver injury. However, few studies investigated liver injury in patients with COVID‐19 with …

Aim Coronavirus disease 2019 (COVID-19) is a recently encountered disease that was
declared a pandemic by WHO in 2020. Obesity and other components of the metabolic …

Abstract Background Initial evidence from China suggests that most vulnerable subjects to
COVID‐19 infection suffer from pre‐existing illness, including metabolic abnormalities. The …

Methods From January 20 through February 17, 2020, consecutive patients admitted to 2
designated COVID-19 Hospitals in China with confirmed COVID-19 and information on …

Background Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease
associated with systemic changes in immune response, which might be associated with …

Background Research on the association of non-alcoholic fatty liver disease (NAFLD) with
prognosis in COVID-19 has been limited. We investigated the association between the fatty …

The impact of the coronavirus disease 2019 (COVID‐19) pandemic among patients with
chronic liver disease is unknown. Given the high prevalence of nonalcoholic fatty liver …

Abstract The coronavirus disease 2019 (COVID-19) is caused by the severe acute
respiratory syndrome coronavirus type 2 (SARS-CoV-2). At present, the COVID-19 has been …

Background & aims Although metabolic risk factors are associated with more severe COVID-
19, there is little evidence on outcomes in patients with non-alcoholic fatty liver disease …

Background & Aims The coronavirus disease 2019 (COVID-19) pandemic has witnessed
more than 4.5 million deaths as of the time of writing. Whether nonalcoholic fatty liver …